Figure 1: Relative Change From Baseline In Fev1% Predicted (Tobramycin Fig1)
Tobramycin Solution
Product Images NDC 59651-129
22 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 59651-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure H (Tobramycin Fig10)
Figure I (Tobramycin Fig11)
Figure J (Tobramycin Fig12)
Figure K (Tobramycin Fig13)
Figure L (Tobramycin Fig14)
Figure M (Tobramycin Fig15)
Figure N (Tobramycin Fig16)
Figure O (Tobramycin Fig17)
Figure P (Tobramycin Fig18)
Figure Q (Tobramycin Fig19)
Figure 2: Absolute Change From Baseline In Log10 Cfus (Tobramycin Fig2)
Package Label-principal Display Panel (300 mg per 5 mL)
Package Label-principal Display Panel (300 mg per 5 mL)
Figure A (Tobramycin Fig3)
Figure B (Tobramycin Fig4)
Figure C (Tobramycin Fig5)
Figure D (Tobramycin Fig6)
Figure E (Tobramycin Fig7)
Figure F (Tobramycin Fig8)
Figure G (Tobramycin Fig9)
Chemical Structure (Tobramycin Str)
